Vertex Pharmaceuticals
VRTX
#190
Rank
S$146.00 B
Marketcap
S$569.48
Share price
-1.67%
Change (1 day)
1.19%
Change (1 year)

Market capitalization of Vertex Pharmaceuticals (VRTX)

Market cap: S$146.00 Billion

As of January 2026 Vertex Pharmaceuticals has a market cap of S$146.00 Billion. This makes Vertex Pharmaceuticals the world's 190th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Vertex Pharmaceuticals from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026S$146.00 B-4.18%
2025S$152.37 B6.49%
2024S$143.08 B3.33%
2023S$138.47 B39.34%
2022S$99.37 B31.53%
2021S$75.55 B-7.07%
2020S$81.30 B6.35%
2019S$76.45 B32.34%
2018S$57.76 B13.96%
2017S$50.69 B91.68%
2016S$26.44 B-39.68%
2015S$43.84 B15.52%
2014S$37.95 B72.44%
2013S$22.00 B97.67%
2012S$11.13 B24.12%
2011S$8.97 B-2.32%
2010S$9.18 B-23.65%
2009S$12.02 B95.62%
2008S$6.14 B38.44%
2007S$4.44 B-38.62%
2006S$7.23 B45.24%
2005S$4.98 B257.77%
2004S$1.39 B1.51%
2003S$1.37 B-34.66%
2002S$2.09 B-38.54%
2001S$3.41 B-53.75%
2000S$7.38 B393.54%
1999S$1.49 B20.17%
1998S$1.24 B-11.22%
1997S$1.40 B18.06%
1996S$1.18 B

End of Day market cap according to different sources

On Jan 14th, 2026 the market cap of Vertex Pharmaceuticals was reported to be:

S$146.94 Billion
by Nasdaq info icon info icon
S$148.49 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
S$196.16 B 34.35%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$495.16 B 239.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$356.55 B 144.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$147.99 B 1.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$680.00 B 365.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
S$0.50 B-99.66%๐Ÿ‡บ๐Ÿ‡ธ USA